Thrombocytopenia after a single test dose of methotrexate

Journal of the American Academy of Dermatology

Volumn 39, Issue 2 II, 1998, Pages 349-351

  Jih, D M ^a   Werth, V P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ETODOLAC; HYDROXYCHLOROQUINE; IBUPROFEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SARCOIDOSIS; THROMBOCYTOPENIA;

EID: 0031816514     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70387-1     Document Type: Article

References (20)

1. GF Webster LK Razsi M Sanchez JL. Shupack Weekly low-dose methotrexate therapy for cutaneous sarcoidosis J Am Acad Dermatol 24 1991 451 454
2. CA Wallace DD. Sherry A practical approach to avoidance of methotrexate toxicity J Rheumatol 22 6 1995 1009 1011
3. TA Goodman RP. Polisson Methotrexate: adverse reactions and major toxicities Rheum Dis Clin North Am 20 2 1994 513 528
4. JA Flynn DB. Hellmann Methotrexate in rheumatoid arthritis: when NSAIDS fail Cleveland Clin J Med 62 6 1995 351 359
5. A Al-Awadhi P Dale RJR. McKendry Pancytopenia associated with low dose methotrexate therapy: a regional survey J Rheumatol 20 1993 1121 1125
6. MD. Weinblatt Methotrexate in rheumatoid arthritis: toxicity issues Br J Rheum 35 1996 403 406
7. B Bannwarth F Pehourcq T Schaeverbeke T. Dehais Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis Clin Pharmacokinet 30 3 1996 194 210
8. GS Alarcon IC Tracy D. Blackburn Methotrexate in rheumatoid arthritis. Toxic effect as the major factor in limiting long-term treatment Arthritis Rheum 32 1989 671 676
9. TW Rooney DE. Furst Comparison of toxicity in methotrexate treated rheumatoid arthritis patients also taking aspirin or other NSAID Arthritis Rheum 29 4 1986 76
10. CF Stewart RA Fleming CR Arkin WE. Evans Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis Clin Pharmacol Ther 47 1990 540 546
11. KJ Skeith AS Russell F Jamali J Coates H. Friedman Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis J Rheumatol 17 1990 1008 1010
12. JM Kremer RA. Hamilton The effects of nonsteroidal antiinflammatory drugs on methotrexate pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg J Rheumatol 22 11 1995 2072 2077
13. TS Tracy K Krohn DR Jones JD Bradley SD. Hall The effects of salicylate, ibuprofen and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis Eur J Clin Pharmacol 42 1992 121 125
14. CF Stewart RA Fleming BF Germain MJ Seleznick WE. Evans Aspirin alters methotrexate disposition in rheumatoid arthritis patients Arthritis Rheum 34 1991 1514 1520
15. L Slordal G Sager R Jaeger J. Aarbakke Interactions with the protein binding of 7-hydroxy-methotrexate in human serum in vitro Biochem Pharmacol 37 1988 607 611
16. JL Shupack GF. Webster Pancytopenia following low-dose oral methotrexate therapy for psoriasis JAMA 259 1988 3594 3596
17. SG Kevat WR Hill PJ McCarthy MJ. Ahern Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis Aust NZ J Med 18 1988 697 700
18. H Franck R Rau G. Herborn Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate Clin Rheumatol 15 2 1996 163 167
19. A Hassell P. Dawes Serious problems with methotrexate? Br J Rheumatol 33 1994 1001 1006
20. M Ahern J Booth A Loxton P McCarthy P Meffin S. Kevat Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs? J Rheumatol 15 1988 1356 1360